14 January 2020

New Algorithm Predicts Gestational Diabetes

A new computer algorithm can predict during early stages of pregnancy, or even before pregnancy, which women are at a high risk of gestational diabetes, according to a study by researchers at the Weizmann Institute of Science reported in Nature Medicine.

The study analysed data on nearly 600,000 pregnancies available from Israel’s largest health organization, Clalit Health Services. Based on these predictions, it may be possible to prevent gestational diabetes using nutritional and lifestyle changes.

“Our ultimate goal has been to help the health system take measures so as to prevent diabetes from occurring in pregnancy,” said senior author Professor Eran Segal of the Computer Science and Applied Mathematics and the Molecular Cell Biology Departments.

Gestational diabetes is characterised by high blood sugar levels that develop during pregnancy in women who did not previously have diabetes. It occurs in 3-9 percent of all pregnancies and is fraught with risks for both mother and baby.

Typically, gestational diabetes is diagnosed between the 24th and 28th weeks of pregnancy, with the help of a glucose tolerance test in which the woman drinks a glucose solution and then undergoes a blood test to see how quickly the glucose is cleared from her blood.

In the new study, Segal and colleagues started out by applying a machine learning method to Clalit’s health records on some 450,000 pregnancies in women who gave birth between 2010 and 2017. Gestational diabetes had been diagnosed by glucose tolerance testing in about 4 percent of these pregnancies.

After processing big data – an enormous dataset made up of more than 2,000 parameters for each pregnancy, including the woman’s blood test results and her and her family’s medical histories – the scientists’ algorithm revealed that nine of the parameters were sufficient to accurately identify the women who were at a high risk of developing gestational diabetes.

The nine parameters included the woman’s age, body mass index, family history of diabetes and results of her glucose tests during previous pregnancies (if any).

Next, to make sure that the nine parameters could indeed accurately predict the risk of gestational diabetes, the researchers applied them to Clalit’s health records on about 140,000 additional pregnancies that had not been part of the initial analysis. The results validated the study’s findings: The nine parameters helped to accurately identify the women who ultimately developed gestational diabetes.

These findings suggest that by having a woman answer just nine questions, it should be possible to tell in advance whether she is at a high risk of developing gestational diabetes.

In addition, if this information is available early on – in the early stages of pregnancy or even before the woman has gotten pregnant – it might be possible to reduce her risk of diabetes through lifestyle measures such as exercise and diet. Also women identified by the questionnaire as being at a low risk of gestational diabetes may be spared the cost and inconvenience of the glucose testing.

Click here to access the self-assessment questionnaire for gestational diabetes.

In more general terms, this study has demonstrated the usefulness of large human-based datasets, specifically electronic health records, for deriving personalized disease predictions that can lead to preventive and therapeutic measures.

The work was led by graduate students Nitzan Shalom Artzi, Dr Smadar Shilo and Hagai Rossman from Eran Segal’s lab at the Weizmann Institute of Science, who collaborated with Professor Eran Hadar, Dr Shiri Barbash-Hazan, Professor Avi Ben-Haroush and Professor Arnon Wiznitzer of the Rabin Medical Center in Petah Tikva; and Professor Ran D. Balicer and Dr Becca Feldman of Clalit Health Services.

Recent blog posts

view all +

17 September 2020 | Videos, Weizmann in Israel

Bacteria Could Provide Us with the Next Antivirals

By tracking the evolution of what may be our oldest means of fighting off viral infection, a group at the Weizmann Institute of Science has uncovered a gold mine of...

read more +

16 September 2020 | Weizmann in Israel

Profiling COVID-19

A research team at the Weizmann Institute of Science and Israel Institute for Biological Research, in Ness Ziona, Israel, has a new approach to understanding the COVID-19 virus that may...

read more +

9 September 2020 | Weizmann in Israel, Weizmann in the News

Young at Heart: Restoring Cardiac Function with a Matrix Molecule

Pre-clinical studies at the Weizmann Institute of Research suggest a protein called Agrin could limit scarring and promote natural repair mechanisms after a heart attack. Heart disease is the number...

read more +